COVID-19 RESILIENCE FINANCE CERTIFICATION SCHEME

Industrial Bank Co., Ltd. Hong Kong Branch

Industrial Bank COVID-19 Response Bond 2020 ("COVID-19 Bond")

兴业银行 2020 年疫情防控债券

HKQAA Reference Number: 14731493-CA,14731524-CA

HKQAA-F1258-HKO-1E-OB 29 May 2020 (#4082536)

Page 1

COVID-19 RESILIENCE FINANCE CERTIFICATION SCHEME

Industrial Bank Co., Ltd. (hereinafter referred to as Industrial Bank) was established in Fuzhou City, Fujian Province in 1988 with a registered capital of 20.774 billion yuan and listed on the Shanghai Stock Exchange in 2007 (stock code: 601166). It's one of the first joint-stock commercial banks approved by the State Council and the People's Bank of China, and it's also the first Equator Bank in China. Now it has grown into a mainstream commercial banking group with banking as its main business and multiple fields such as trust, financial lease, funds, futures, asset management, consumer finance, research and consulting, and digital finance covered, ranking among the top 30 banks in the world and Fortune Global 500.

Use of Proceeds

Overall

Percentage of proceeds

100%

committed for COVID-

19 resilience

Eligible Project

∙ Support the working capital of hospitals or medical service providers

Category for COVID-19

resilience

∙ Support the production of preventive medical clothing, medical masks and disinfectants

∙ Support pharmaceutical companies and for the production, R&D and distribution of

medicines or vaccination

∙ Support the production of medical equipment / vehicles

∙ Support a stable supply of essentials during the pandemics

∙ Support renovation work of hospitals

The use of the

%

Use of proceeds

remaining proceeds

0%

N/A, as 100% of the proceeds will be committed for COVID-19 resilience

Refinancing

☑ Yes, refinancing involved

An estimate of the share

Which investments or

Expected look-back

of proceeds for re-

project portfolios may be

period1 for refinanced

financing

refinanced

project

100%

Loans to Eligible Project

The value date of all

Categories for COVID-19

eligible loans is after 1st

resilience as defined in

February 2020

"Use of Proceeds" section

of this COVID-19

Resilience Finance

Certification Scheme

Framework Statement

Template (the "Template")

No, refinancing not involved.

Declaration

☑ We committed that proceeds will not be allocated to activities stated in Project Exclusion

List (reference with IFC Exclusion List)

(Replicate the table below for more than one eligible project category)

Name of Eligible Project Category: Support the working capital of hospitals or medical service providers

1 Look back period refers to a maximum period in the past that an Issuer will look back to identify assets/earlier disbursements to such eligible projects that will be included in the reporting

HKQAA-F1258-HKO-1E-OB 29 May 2020 (#4082536)

Page 2

COVID-19 RESILIENCE FINANCE CERTIFICATION SCHEME

Intended benefit to

Corresponding SDG

SDG 3

resilience of COVID-19

Social issues

The COVID-19 outbreak threatens the well-being of the world's

population, especially those with limited access to health and

medical services

Target Population

Given the widespread nature of the COVID-19 pandemic, the

(i.e. the beneficiary)

asset is expected to benefit the general populace. Benefits

would be especially expected for those most vulnerable to the

COVID-19, including those with limited access to health and

medical services

Intended Social

The eligible loans are expected to create positive health

Outcome

outcomes potentially as a result of improved access to health

and medical service

Eligibility criteria

∙ Loans to support the working capital of hospitals or medical service providers

Key Performance

KPI (unit)

How to measure the

Indicator (KPI)

KPI (Key underlying methodology and/or assumptions, e.g.

baseline)

Number of companies

When IB identify the potential eligible loan portfolio, all of

supported

the Eligible loans under the portfolio already align with the

Overall objective: Increase

overall objective KPIs (e.g. maintenance original service

access to essential health

level / expansion the production capacity). The overall

care services

objective KPIs will be recorded in the Eligible Loan list.

Relevant branches or departments will check if there are

any material changes on the Eligible Loan, and report to the

working group. The material changes will be recorded in the

Eligible Loan list.

KPI measurement -

International Standard

Reference standard

National Standard

Industry Standard

☑Self-development Standard

Others, Please specify: _____________________________________

Any significant

Yes, please specify the risk and mitigation measure:

environmental and

social risk constituted

☑No significant environmental and social risk identified

by this type of project

activities

Name of Eligible Project Category: Support the production of preventive medical clothing, medical masks and disinfectants

Intended benefit to

Corresponding SDG

SDG 3

resilience of COVID-19

Social issues

The COVID-19 outbreak threatens the well-being of the world's

population, especially those with limited access to medical and

preventive equipment

Target Population

Given the widespread nature of the COVID-19 pandemic, the

(i.e. the beneficiary)

asset is expected to benefit the general populace. Benefits

would be especially expected for those most vulnerable to the

COVID-19, including those with limited access medical and

preventive equipment

Intended Social

The Eligible loans are expected to create positive health

Outcome

outcomes potentially as a result of reduction in the spread of the

virus among users of the medicine, equipment and supplies

Eligibility criteria

∙ Loans to support the production of preventive medical clothing, medical masks and

disinfectants

Key Performance

KPI (unit)

How to measure the KPI (Key underlying methodology

Indicator (KPI)

and/or assumptions, e.g. baseline)

Number of companies

When IB identify the potential eligible loan portfolio, all of

HKQAA-F1258-HKO-1E-OB

29 May 2020 (#4082536)

Page 3

COVID-19 RESILIENCE FINANCE CERTIFICATION SCHEME

supported

the Eligible loans under the portfolio already align with the

Overall objective: Increase

overall objective KPIs (e.g. maintenance original service

the production capacity of

level / expansion the production capacity). The overall

preventive medical clothing,

objective KPIs will be recorded in the Eligible Loan list.

medical masks and

Relevant branches or departments will check if there are

disinfectants

any material changes on the Eligible Loan, and report to

the working group. The material changes will be recorded

in the Eligible Loan list.

KPI measurement -

International Standard

Reference standard

National Standard

Industry Standard

☑Self-development Standard

Others, Please specify: _____________________________________

Any significant

Yes, please specify the risk and mitigation measure:

environmental and

☑No significant environmental and social risk identified

social risk constituted

by this type of project

activities

Name of Eligible Project Category: Support pharmaceutical companies and for the production, R&D and distribution of medicines or vaccination

Intended benefit to

Corresponding SDG

SDG 3

resilience of COVID-19

Social issues

The COVID-19 outbreak threatens the well-being of the world's

population, especially those with limited access to medicine or

vaccination

Target Population

Given the widespread nature of the COVID-19 pandemic, the

(i.e. the beneficiary)

asset is expected to benefit the general populace. Benefits

would be especially expected for those most vulnerable to the

COVID-19, including those with limited access to medicine or

vaccination

Intended Social

The Eligible loans are expected to create positive health

Outcome

outcomes potentially as a result of the pharmaceutical, medical

and vaccine research and development

Eligibility criteria

∙ Loans to support pharmaceutical companies and for the production, R&D and

distribution of medicines or vaccination

Key Performance

KPI (unit)

How to measure the KPI (Key underlying methodology

Indicator (KPI)

and/or assumptions, e.g.? baseline)

Number of companies

When IB identify the potential eligible loan portfolio, all of

supported

the Eligible loans under the portfolio already align with the

Overall objective: Contribute

overall objective KPIs (e.g. maintenance original service

to medical and

level / expansion the production capacity). The overall

pharmaceutical research

objective KPIs will be recorded in the Eligible Loan list.

and development, including

Relevant branches or departments will check if there are

but not limited to COVID-19

any material changes on the Eligible Loan, and report to

test, vaccines and/or other

the working group. The material changes will be recorded

medications intended to

in the Eligible Loan list.

alleviate symptoms of the

infectious virus

KPI measurement -

International Standard

Reference standard

National Standard

Industry Standard

☑Self-development Standard

Others, Please specify: _____________________________________

Any significant

Yes, please specify the risk and mitigation measure:

environmental and

social risk constituted

☑No significant environmental and social risk identified

by this type of project

activities

Name of Eligible Project Category: Support the production of medical equipment / vehicles

HKQAA-F1258-HKO-1E-OB

29 May 2020 (#4082536)

Page 4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Industrial Bank Co. Ltd. published this content on 30 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 October 2020 01:29:03 UTC